glp 1 long term studies In recent years, GLP-1 medications have transformed obesity treatment, producing unprecedented amounts of weight loss in clinical trials. But they come with an important challenge... What happens when people stop taking them? Long-term Success of GLP-1s Hinges
Description
SGLT-2 accounts for the majority of glucose reabsorption in the kidney and has, thus, surfaced as a therapeutic target for the treatment of T2DM
[DOI] [PubMed] [Google Scholar] 57.Secher A, Jelsing J, Baquero AF, Hecksher-Sorensen J, Cowley MA, Dalboge LS, et al
The bigger safety concern is false reliance: using ineffective OTC products delays access to evidence-based alternatives
The question then becomes not whether AI will transform pharma, but how fast and in what new directions
What to expect during GLP-1 Treatment
2008;3(Suppl 2):S2937
